Tesamorelin, a synthetic peptide copy of GHRH , is largely utilized in the treatment of visceral obesity in individuals suffering from HIV. This medication works by prompting the release of growth hormone from the pituitary gland , which in sequence can aid in reducing abdominal fat accumulation . While not any solution for HIV itself, tesamorelin

Innovative retatrutide, a twin -action medication targeting simultaneously GLP-1 and GIP receptors, is generating considerable interest within the weight loss community. Preliminary clinical research have demonstrated substantial losses in body size and gains in physiological markers for patients with excess weight . Scientists believe this unique